BIIB Biogen Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

BIIB [NASD]

Biogen Inc.

Healthcare | Drug Manufacturers - General | USA

statements

Index	S&P 500	P/E	8.06	EPS (ttm)	30.21	Insider Own	0.10%	Shs Outstand	156.90M	Perf Week	-3.02%
Market Cap	37.43B	Forward P/E	9.57	EPS next Y	25.43	Insider Trans	-0.97%	Shs Float	152.92M	Perf Month	-8.78%
Income	5.08B	PEG	-	EPS next Q	5.04	Inst Own	88.20%	Short Float	2.48%	Perf Quarter	-12.00%
Sales	14.26B	P/S	2.62	EPS this Y	44.80%	Inst Trans	-2.69%	Short Ratio	2.30	Perf Half Y	-17.74%
Book/sh	68.57	P/B	3.55	EPS next Y	-24.26%	ROA	19.60%	Target Price	290.37	Perf Year	-15.63%
Cash/sh	23.28	P/C	10.46	EPS next 5Y	-4.92%	ROE	42.40%	52W Range	223.25 - 374.99	Perf YTD	-17.98%
Dividend	-	P/FCF	5.87	EPS past 5Y	20.50%	ROI	30.50%	52W High	-35.10%	Beta	0.54
Dividend %	-	Quick Ratio	1.80	Sales past 5Y	8.20%	Gross Margin	87.60%	52W Low	9.02%	ATR	14.69
Employees	7400	Current Ratio	2.10	Sales Q/Q	-6.20%	Oper. Margin	46.70%	RSI (14)	44.97	Volatility	2.50% 5.35%
Optionable	Yes	Debt/Eq	0.69	EPS Q/Q	-46.80%	Profit Margin	35.60%	Rel Volume	0.76	Prev Close	244.15
Shortable	Yes	LT Debt/Eq	0.69	Earnings	Oct 21 BMO	Payout	0.00%	Avg Volume	1.65M	Price	243.38
Recom	2.70	SMA20	-5.21%	SMA50	-9.76%	SMA200	-16.03%	Volume	1,247,867	Change	-0.32%

Nov-10-20

Upgrade

DZ Bank

Hold → Buy

$265

Nov-09-20

Reiterated

H.C. Wainwright

Buy

$318 → $289

Nov-09-20

Downgrade

Cowen

Outperform → Market Perform

$215

Nov-09-20

Downgrade

BofA Securities

Neutral → Underperform

$240

Nov-09-20

Downgrade

Atlantic Equities

Neutral → Underweight

$175

Nov-04-20

Upgrade

Wells Fargo

Equal Weight → Overweight

$390

Nov-04-20

Upgrade

Jefferies

Hold → Buy

$450

Nov-04-20

Upgrade

BofA Securities

Underperform → Neutral

Oct-28-20

Initiated

UBS

Neutral

$268

Jul-27-20

Upgrade

Morgan Stanley

Underweight → Overweight

$263 → $357

Jun-22-20

Reiterated

RBC Capital Mkts

Sector Perform

$303 → $273

Jun-22-20

Downgrade

Barclays

Overweight → Equal Weight

$370 → $280

Jun-09-20

Downgrade

Bernstein

Outperform → Mkt Perform

$360 → $297

Apr-23-20

Downgrade

Raymond James

Mkt Perform → Underperform

Apr-23-20

Downgrade

Citigroup

Neutral → Sell

$365 → $240

Mar-31-20

Initiated

Wolfe Research

Peer Perform

Feb-27-20

Initiated

Barclays

Overweight

$389

Jan-27-20

Upgrade

Canaccord Genuity

Hold → Buy

$360

Dec-13-19

Upgrade

Credit Suisse

Underperform → Neutral

$260 → $300

Dec-02-19

Downgrade

Robert W. Baird

Neutral → Underperform

Nov-23-20 10:00PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB ACCESSWIRE
07:47PM	BIIB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 12, 2021 in the Class Action Filed on Behalf of Biogen Inc. Limited Shareholders Newsfile
06:21PM	DEADLINE FOR BIIB INVESTORS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Biogen Inc. Newsfile
04:45PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PT, BTU and BIIB ACCESSWIRE
03:55PM	IMPORTANT INVESTOR DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Biogen Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
03:44PM	The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Biogen, Inc. (BIIB) Investors Business Wire
12:28PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Biogen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 12, 2021 - BIIB Newsfile
11:00AM	BIIB Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Biogen Inc. Investors of Class Action and Encourages Investors to Contact the Firm Business Wire
06:20AM	LAWSUITS FILED AGAINST TRQ, RTX and BIIB - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
Nov-22-20 05:30PM	ROSEN, A TOP RANKED LAW FIRM, Reminds Biogen Inc. Investors of Important January 12 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of $1 Million to Contact the Firm BIIB GlobeNewswire
11:00AM	BIOGEN INVESTOR ALERT: SHAREHOLDER LAWSUIT FILED Newsfile
07:05AM	3 Best Pharma Stocks to Buy Right Now Motley Fool
03:17AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB GlobeNewswire
Nov-20-20 07:26PM	BIIB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 12, 2021 in the Class Action Filed on Behalf of Biogen Inc. Limited Shareholders Newsfile
06:00PM	IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Biogen Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
05:50PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GLNG, BIIB and LRN ACCESSWIRE
04:59PM	BIIB INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit has been Filed Against Biogen Inc. PR Newswire
03:10PM	BIOGEN INVESTOR ALERT: Shareholder Lawsuit Filed ACCESSWIRE
01:30PM	CLASS ACTION UPDATE for FLDM, GLNG and BIIB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
01:00PM	BIIB Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Biogen Inc. Investors of Class Action and Encourages Investors to Contact the Firm ACCESSWIRE
09:33AM	Nasdaq-100 Laggards Could Offer Timely Short Sales Investopedia
Nov-19-20 07:52PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Biogen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 12, 2021 - BIIB Newsfile
06:19PM	ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds Biogen Inc. Investors of Important January 12 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of $1 Million to Contact the Firm - BIIB PR Newswire
05:15PM	SHAREHOLDER ALERT: FLDM GLNG BIIB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
04:15PM	IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Biogen Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
04:05PM	CLASS ACTION UPDATE for GOCO, CACC and BIIB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:30PM	The Law Offices of Frank R. Cruz Announces Investigation of Biogen, Inc. (BIIB) on Behalf of Investors Business Wire
01:30PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BTU, LVS and BIIB ACCESSWIRE
01:03PM	Top Healthcare Stocks for December 2020 Investopedia
01:00PM	INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Biogen, Inc. (BIIB) on Behalf of Investors Business Wire
11:45AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TCMD, BIIB and BABA ACCESSWIRE
11:00AM	BIIB Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Biogen Inc. Investors of Class Action and Encourages Investors to Contact the Firm GlobeNewswire
10:17AM	BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. BIIB GlobeNewswire
06:40AM	2 Bargain Stocks You Can Buy Right Now Motley Fool
Nov-18-20 09:15PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MESO, RTX and BIIB ACCESSWIRE
09:00PM	Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intercept Pharmaceuticals, Neovasc, Interface, and Biogen and Encourages Investors to Contact the Firm GlobeNewswire
08:30PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB ACCESSWIRE
08:17PM	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Biogen, Inc. (BIIB) on Behalf of Investors Business Wire
04:25PM	SHAREHOLDER ALERT: TCMD RTX BIIB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
04:05PM	BIOGEN INVESTOR ALERT: Shareholder Lawsuit Filed ACCESSWIRE
03:50PM	SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Biogen Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
02:00PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of RCL, LVS and BIIB ACCESSWIRE
01:00PM	BIIB Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Biogen Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm ACCESSWIRE
10:40AM	CLASS ACTION UPDATE for FLDM, TRQ and BIIB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
07:00AM	Samsung Bioepis and Biogen Announce FDA Filing Acceptance of SB11, A Proposed Biosimilar Referencing Lucentis® (ranibizumab) GlobeNewswire
06:08AM	Here's Exactly Why Warren Buffett Loaded Up on Big Pharma Stocks Motley Fool
Nov-17-20 03:02PM	ROSEN, A LEADING LAW FIRM, Reminds Biogen Inc. Investors of Important Deadline in Securities Class Action Commenced by the Firm; Encourages Investors with Losses in Excess of $1 Million to Contact the Firm BIIB Business Wire
02:46PM	SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Biogen Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
01:25PM	IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Biogen Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
11:00AM	BIIB Shareholder Notification: Bronstein, Gewirtz & Grossman, LLC Notifies Biogen Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm PR Newswire
Nov-16-20 10:57PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB GlobeNewswire
03:35PM	FIRST FILING AND GLOBAL ROSEN LAW FIRM, Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $1 million to Contact Counsel BIIB ACCESSWIRE
02:50PM	IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Biogen Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
01:00PM	BIIB Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Biogen Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm ACCESSWIRE
07:30AM	Biogen Ranked #1 Biotechnology Company by Dow Jones Sustainability World Index for an Industry Record 5th Time; Recognition Reflects Longstanding ESG Leadership GlobeNewswire
Nov-15-20 07:04AM	2 Top Pharma Stocks to Watch in November Motley Fool
Nov-14-20 03:30PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB ACCESSWIRE
03:00PM	ROSEN, GLOBAL INVESTOR COUNSEL, Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm BIIB GlobeNewswire
07:31AM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Biogen Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
Nov-13-20 08:00PM	BIOGEN ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Biogen, Inc. and Encourages Investors to Contact the Firm GlobeNewswire
05:00PM	TOP RANKED ROSEN LAW FIRM Files First Securities Class Action Lawsuit Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact the Firm - BIIB PR Newswire
02:45PM	BIIB Shareholder Notification: Bronstein, Gewirtz & Grossman, LLC Notifies Biogen Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm ACCESSWIRE
02:04PM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Biogen Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
12:09PM	These are the 14 value stocks that top-performing investment newsletters like the most MarketWatch
10:50AM	EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Biogen Inc. BIIB Business Wire
Nov-12-20 08:00PM	BIOGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Biogen, Inc. on Behalf of Biogen Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
07:51PM	ROSEN, A LEADING AND LONGSTANDING FIRM, Announces Investigation of Securities Claims Against Biogen Inc. - BIIB PR Newswire
11:18AM	Does Good News About Biogen's Alzheimer's Drug Mean Bad News for Rivals? Motley Fool
Nov-11-20 09:49PM	PSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB PR Newswire
04:55PM	ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Biogen Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm Newsfile
10:01AM	SHAREHOLDER ALERT: Investigation of Biogen Announced by Holzer & Holzer, LLC Newsfile
07:30AM	Is Biogen Stock A Buy After An FDA Panel Rejected Its Alzheimer's Drug? Investor's Business Daily
06:09AM	Why Warren Buffett's Riskiest Bet in Years Is on the Brink of Bombing Motley Fool
05:39AM	If You Had Bought Biogen's (NASDAQ:BIIB) Shares Three Years Ago You Would Be Down 24% Simply Wall St.
Nov-10-20 01:26PM	INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Biogen Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm Business Wire
Nov-09-20 06:11PM	Biogen Stock Gave Back Last Weeks Gains. Heres Whats Next. Barrons.com -28.17%
04:28PM	Rosen, A Global and Leading Law Firm, Announces Investigation of Securities Claims Against Biogen Inc.; Encourages Investors with Losses in Excess of $500K to Contact Firm - BIIB Newsfile
04:13PM	Biogen Stock Crashes After FDA Panel Rejects Alzheimer's Treatment Investor's Business Daily
01:18PM	Biogen Inc. -- Moody's review's Biogen's Baa1 ratings for downgrade Moody's
12:55PM	INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Biogen Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm Business Wire
12:00PM	Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Biogen Inc. (BIIB) Investigation ACCESSWIRE
11:21AM	EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Biogen Inc. BIIB Business Wire
10:05AM	Dow Jones Today Seizes Record High On Biden Presidency, Pfizer Vaccine News Investor's Business Daily
09:52AM	Biogen Plunges After Alzheimers Blow, Analysts Downgrade Bloomberg
09:44AM	The Zacks Analyst Blog Highlights: QUALCOMM, Intuit, Boeing, Biogen and Ally Financial Zacks
09:38AM	ROCE Insights For Biogen Benzinga
09:37AM	Biogen Plunges After FDA Panel Rejects Alzheimer's Drug TheStreet.com
09:00AM	Why Biogen Stock Is Tanking Today Motley Fool
08:22AM	Dow Jones Futures Surge As Pfizer/BioNTech Coronavirus Vaccine Effective, Tech Futures Slash Gains In Market Rally Shakeup Investor's Business Daily
08:06AM	Biogen plunges 30% after FDA panel votes against Alzheimer's drug Reuters
07:42AM	Biogen Alzheimer's Drug Aducanumab Gets Rejected by FDA Panel Zacks
07:40AM	Biogens Alzheimers Drug Hit a Major Roadblock. The Stock Still Isnt a Buy. Barrons.com
07:22AM	Pfizer, Biden, Biogen, McDonald's, Beyond Meat - 5 Things You Must Know Monday TheStreet.com
06:43AM	Dow Jones Futures: After Huge Stock Market Rally, Biotech Giant Set To Dive; Tesla, China EV Stocks Rise Investor's Business Daily
05:51AM	Analysts Predict Volatility In Biogen Shares Until March 2021 Benzinga
Nov-08-20 05:23PM	Stock Market Rally Wins In Landslide, Nvidia In Buy Range; Do This Before Monday's Open Investor's Business Daily
11:44AM	Barron's Picks And Pans: Apollo Global, Biogen, Biden Picks And More Benzinga
Nov-07-20 09:37AM	Biogen Bombs at the FDA Panel; J.P. Morgan Weighs In TipRanks
04:31AM	Combative U.S. FDA panel votes against Biogen Alzheimer's drug Reuters
Nov-06-20 08:51PM	Biogen Alzheimers Drug Fails to Gain FDA Panels Backing Bloomberg

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of relapsing MS and primary progressive MS; and other anti-CD20 therapies. Further, it is involved in developing Opicinumab, BIIB061, and BIIB091 for MS and neuroimmunology; Aducanumab, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB067, BIIB078, BIIB110, and BIIB100 to treat neuromuscular disorders; BIIB054 and BIIB094 for treating movement disorders; BIIB111 and BIIB112 for ophthalmology; Dapirolizumab pegol and BIIB059 to treat immunology and others; BIIB104 for neurocognitive disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB074 and BIIB095 for pain; and SB11 biosimilar, which are under various stages of development. The company offers products through its sales force and marketing groups. It has collaboration agreements with Genentech, Inc.; Ionis Pharmaceuticals, Inc.; Eisai Co., Ltd.; Alkermes Pharma Ireland Limited; Bristol-Myers Squibb Company; Acorda Therapeutics, Inc.; AbbVie Inc.; Skyhawk Therapeutics, Inc.; Neurimmune SubOne AG; Scribe Therapeutics Inc.; and Sangamo Therapeutics Inc. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sandrock Alfred	EVP, Research & Development	Nov 04	Sale	350.00	1,500	525,000	13,066	Nov 06 09:39 PM
Gregory Ginger	EVP, Human Resources	Jul 31	Option Exercise	0.00	212	0	4,786	Aug 04 04:12 PM
SHERWIN STEPHEN A	Director	Mar 11	Option Exercise	58.46	12,278	717,772	16,517	Mar 12 06:56 PM
SHERWIN STEPHEN A	Director	Mar 11	Sale	295.22	2,434	718,574	14,353	Mar 12 06:56 PM
Vounatsos Michel	Chief Executive Officer	Feb 15	Option Exercise	0.00	4,847	0	33,775	Feb 19 06:20 PM
Sandrock Alfred	EVP, Research & Development	Feb 15	Option Exercise	0.00	1,213	0	15,019	Feb 19 06:17 PM
Galdes Alphonse	EVP Pharmaceutical Oper & Tech	Feb 15	Option Exercise	0.00	441	0	2,672	Feb 19 06:13 PM
ALEXANDER SUSAN H	EVP Chief Legal Off & Corp Sec	Feb 15	Option Exercise	0.00	1,553	0	37,261	Feb 19 06:09 PM
Kramer Robin	VP, Chief Accounting Officer	Feb 12	Option Exercise	0.00	132	0	282	Feb 14 06:37 PM
Karp Daniel	EVP, Corporate Development	Feb 12	Option Exercise	0.00	960	0	1,224	Feb 14 06:36 PM
Guindo Chirfi	EVP Glob. Prod Strat and Comm	Feb 12	Option Exercise	0.00	1,680	0	4,375	Feb 14 06:34 PM
Gregory Ginger	EVP, Human Resources	Feb 12	Option Exercise	0.00	3,547	0	5,021	Feb 14 06:32 PM
Galdes Alphonse	EVP Pharmaceutical Oper & Tech	Feb 12	Option Exercise	0.00	1,154	0	2,337	Feb 14 06:30 PM
CAPELLO JEFFREY D	EVP & Chief Financial Officer	Feb 12	Option Exercise	0.00	1,919	0	3,732	Feb 14 06:27 PM
ALEXANDER SUSAN H	EVP Chief Legal Off & Corp Sec	Feb 12	Option Exercise	0.00	5,967	0	36,389	Feb 14 06:25 PM
Vounatsos Michel	Chief Executive Officer	Feb 12	Option Exercise	0.00	11,994	0	31,483	Feb 14 06:19 PM
Sandrock Alfred	EVP, Research & Development	Feb 12	Option Exercise	0.00	5,216	0	14,509	Feb 14 06:16 PM
CAPELLO JEFFREY D	EVP & Chief Financial Officer	Jan 02	Option Exercise	0.00	1,302	0	2,219	Jan 06 04:14 PM
Kramer Robin	VP, Chief Accounting Officer	Dec 03	Option Exercise	0.00	84	0	175	Dec 05 04:24 PM
Posner Brian S	Director	Dec 02	Sale	292.35	1,055	308,429	6,995	Dec 03 05:58 PM
Guindo Chirfi	EVP Glob. Prod Strat and Comm	Dec 01	Option Exercise	0.00	543	0	2,855	Dec 03 05:59 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience